EVMN

Evommune Inc
EVMN

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$49
99% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
100% 1-yr EVMN win rate
10 Feb ‘26 1 month ago
Oppenheimer
Oppenheimer
Andreas Argyrides
100% 1-yr EVMN win rate
22 Jan ‘26 2 months ago
Raymond James
Raymond James
Martin Auster
100% 1-yr EVMN win rate
8 Jan ‘26 2 months ago